Rapport bags $150M Series B just five months after nine-figure launch for epilepsy, psychiatry trials

Kyle LaHucik

Senior Reporter

Just five months after emerging with $100 million to test former Janssen neuroscience programs, Rapport Therapeutics is back with another nine-figure raise to take its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Rapport bags $150M Series B just five months after nine-figure launch for epilepsy, psychiatry trials

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Takeda to lay off more employees in Massachusetts

Samsung Bio pulls in $1.06B manufacturing deal with unnamed US pharma company

Cartesian clears an autoimmune CAR-T trial, starts another Phase 2 and raises $130M

Four key weight loss readouts to watch at #EASD24

Corrected: Boehringer Ingelheim, Gubra put a second candidate into the obesity race

Cassava says two senior employees included in federal probes

Rap­port bags $150M Se­ries B just five months af­ter nine-fig­ure launch for epilep­sy, psy­chi­a­try tri­als

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

more like this

Take­da to lay off more em­ploy­ees in Mass­a­chu­setts

Sam­sung Bio pulls in $1.06B man­u­fac­tur­ing deal with un­named US phar­ma com­pa­ny

Carte­sian clears an au­toim­mune CAR-T tri­al, starts an­oth­er Phase 2 and rais­es $130M

Four key weight loss read­outs to watch at #EASD24

Cor­rect­ed: Boehringer In­gel­heim, Gubra put a sec­ond can­di­date in­to the obe­si­ty race

Cas­sa­va says two se­nior em­ploy­ees in­clud­ed in fed­er­al probes

Rapport bags $150M Series B just five months after nine-figure launch for epilepsy, psychiatry trials

Takeda to lay off more employees in Massachusetts

Samsung Bio pulls in $1.06B manufacturing deal with unnamed US pharma company

Cartesian clears an autoimmune CAR-T trial, starts another Phase 2 and raises $130M

Four key weight loss readouts to watch at #EASD24

Corrected: Boehringer Ingelheim, Gubra put a second candidate into the obesity race

Cassava says two senior employees included in federal probes